Literature DB >> 22037784

The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.

Christina Justenhoven, Ofure Obazee, Stefan Winter, Fergus J Couch, Janet E Olson, Per Hall, Ulf Hannelius, Jingmei Li, Keith Humphreys, Gianluca Severi, Graham Giles, Melissa Southey, Laura Baglietto, Peter A Fasching, Matthias W Beckmann, Arif B Ekici, Ute Hamann, Christian Baisch, Volker Harth, Sylvia Rabstein, Anne Lotz, Beate Pesch, Thomas Brüning, Yon-Dschun Ko, Hiltrud Brauch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22037784     DOI： 10.1007/s10549-011-1827-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  3 in total

1.  Physical Confirmation and Comparative Genomics of the Rat Mammary carcinoma susceptibility 3 Quantitative Trait Locus.

Authors:  Saasha Le; Zachary C Martin; David J Samuelson
Journal:  G3 (Bethesda)       Date:  2017-06-07       Impact factor: 3.154

2.  Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.

Authors:  Christina Justenhoven
Journal:  Front Genet       Date:  2012-11-28       Impact factor: 4.599

3.  Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer.

Authors:  Derrick G Lee; Johanna M Schuetz; Agnes S Lai; Igor Burstyn; Angela Brooks-Wilson; Kristan J Aronson; John J Spinelli
Journal:  Breast Cancer       Date:  2021-08-05       Impact factor: 4.239
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.